New allergy treatment shows promise for dust mite sufferers
NCT ID NCT07427576
First seen Feb 28, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study tested a type of allergy immunotherapy (Clustoid®) for people with dust mite allergies. It included 140 patients aged 5 to 65 who received the treatment for at least one year. The goal was to see if it reduces allergy symptoms and the need for medication, while also checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clínica Doctor García Robaina
Santa Cruz de Tenerife, Canary Islands, 38002, Spain
-
Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Canary Islands, 38010, Spain
Conditions
Explore the condition pages connected to this study.